Platelet function, coagulopathy, and impaired fibrinolysis in diabetes

Cardiol Clin. 2004 Nov;22(4):511-26. doi: 10.1016/j.ccl.2004.06.009.

Abstract

Diabetes and the metabolic syndrome, including insulin resistance, that underlies it are hyper-coagulable states. Increased platelet reactivity,augmented activity of the coagulation system,and impaired fibrinolysis are characteristic and understood to a remarkable extent. In aggregate,these derangements contribute to accelerated atherosclerosis, premature coronary artery dis-ease, and a profound toll from both.

Publication types

  • Review

MeSH terms

  • Animals
  • Blood Coagulation Factors / metabolism
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / physiopathology
  • Coronary Artery Disease / prevention & control
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / physiopathology*
  • Diabetic Angiopathies / blood
  • Diabetic Angiopathies / physiopathology
  • Fibrinolysis / physiology*
  • Humans
  • Insulin Resistance / physiology
  • Plasminogen Activator Inhibitor 1 / blood
  • Thrombophilia / blood
  • Thrombophilia / physiopathology*

Substances

  • Blood Coagulation Factors
  • Plasminogen Activator Inhibitor 1